On Thursday, consumer healthcare business Haleon (HLN.L) said it expected 2023 organic sales,
growth near the top of its 4%-6% prediction owing to high demand and restocking of its respiratory,
health products after a terrible cold and flu season.
The world’s largest standalone consumer health business, which offers non-prescription medications, vitamins, and dental care, maintained its full-year 2023 outlook.
GSK (GSK.L) spun off Haleon in July.
